US Patent:
20130317123, Nov 28, 2013
Inventors:
MYRIAD GENETICS, INC. - , US
Benoit Leclair - Salt Lake City UT, US
Saradha Rajamani - Salt Lake City UT, US
Jeffrey T. Trost - Salt Lake City UT, US
Jack W. Landon - Salt Lake City UT, US
Benjamin B. Roa - Salt Lake City UT, US
Assignee:
MYRIAD GENETICS, INC. - Salt Lake City UT
International Classification:
C12Q 1/68
US Classification:
514789, 435 611, 436501, 435 792
Abstract:
Large deletions have been identified in the PMS2 gene in patients. The large deletions predispose the patients to Lynch syndrome associated cancers.